This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hill, D. J. Articles by Graham, C. F. Search for Related Content PubMed PubMed Citation Articles by Hill, D. J. Articles by Graham, C. F.

Increased and Persistent Circulating Insulin-Like Growth Factor II in Neonatal Transgenic Mice Suppresses Developmental Apoptosis in the Pancreatic Islets¹

Lawson Research Institute, St. Joseph’s Health Center (D.J.H., B.S., E.A., S.C.), London, Ontario, Canada N6A 4V2; the Departments of Physiology (D.J.H.), Medicine (D.J.H.), and Pediatrics (D.J.H.), University of Western Ontario, London, Ontario, Canada N6A 5A5; and the Department of Zoology, University of Oxford (S.Z., C.F.G.), Oxford, United Kingdom OX1 3PS

Address all correspondence and requests for reprints to: Dr. D. J. Hill, Lawson Research Institute, St. Joseph’s Health Center, 268 Grosvenor Street, London, Ontario, Canada N6A 4V2. E-mail: dhill{at}lri.stjosephs.london.on.ca

In rats, a proportion of pancreatic ß-cells are deleted by apoptosis in the second week of postnatal life and replaced by endocrine cell neogenesis from pancreatic ductal epithelium. This coincides with a reduction in pancreatic insulin-like growth factor II (IGF-II) expression, and IGF-II has been shown to act as a ß-cell survival factor in vitro. To examine whether IGF-II regulates ß-cell apoptosis in vivo, an IGF-II transgenic mouse model was used in which mouse IGF-II is overexpressed in skin, gut, and uterus driven by a keratin promoter, so that circulating IGF-II is retained postnatally. Mice were killed between postnatal days 7 and 26, and the pancreas was examined histologically. Apoptotic cells were visualized by the terminal deoxynucleotidyltransferase-mediated deoxy-UTP nick end labeling method, and proliferating cells were examined by immunohistochemistry for proliferating cell nuclear antigen. In nontransgenic mice, serum IGF-II was absent by 26 days, but mean (±SEM) values were 45 ± 9 ng/ml (n = 5) in transgenic animals. A 2- to 3-fold rise in islet cell apoptosis was seen in normal animals between days 11 and 16, but this was substantially decreased in IGF-II transgenic mice (day 11; control, 12 ± 1%; transgenic, 6 ± 1%; P < 0.01; n = 5). Consequently, islets from IGF-II transgenic mice had a significantly greater mean area from days 11–16, but the proportions of ß- and -cells and circulating insulin levels were not changed. Islet cell DNA synthesis was increased in transgenic mice on days 13 and 16. The total islet number per section did not alter. The results show that a persistent presence of circulating IGF-II postnatally alters endocrine pancreatic ontogeny in the mouse and largely prevents the wave of developmental apoptosis that precipitates ß-cell turnover in neonatal life.

This article has been cited by other articles:

				L. Kappeler, C. De Magalhaes Filho, P. Leneuve, J. Xu, N. Brunel, C. Chatziantoniou, Y. Le Bouc, and M. Holzenberger Early Postnatal Nutrition Determines Somatotropic Function in Mice Endocrinology, January 1, 2009; 150(1): 314 - 323. [Abstract] [Full Text] [PDF]

				K. L. Gatford, S. N. B. Mohammad, M. L. Harland, M. J. De Blasio, A. L. Fowden, J. S. Robinson, and J. A. Owens Impaired {beta}-Cell Function and Inadequate Compensatory Increases in {beta}-Cell Mass after Intrauterine Growth Restriction in Sheep Endocrinology, October 1, 2008; 149(10): 5118 - 5127. [Abstract] [Full Text] [PDF]

				M. M. Bonaventura, P. N. Catalano, A. Chamson-Reig, E. Arany, D. Hill, B. Bettler, F. Saravia, C. Libertun, and V. A. Lux-Lantos GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E157 - E167. [Abstract] [Full Text] [PDF]

				Q. Qiu, J.-Y. Jiang, M. Bell, B. K. Tsang, and A. Gruslin Activation of Endoproteolytic Processing of Insulin-Like Growth Factor-II in Fetal, Early Postnatal, and Pregnant Rats and Persistence of Circulating Levels in Postnatal Life Endocrinology, October 1, 2007; 148(10): 4803 - 4811. [Abstract] [Full Text] [PDF]

				L. Bouwens and I. Rooman Regulation of Pancreatic Beta-Cell Mass Physiol Rev, October 1, 2005; 85(4): 1255 - 1270. [Abstract] [Full Text] [PDF]

				J. Roccisana, V. Reddy, R. C. Vasavada, J. A. Gonzalez-Pertusa, M. A. Magnuson, and A. Garcia-Ocana Targeted Inactivation of Hepatocyte Growth Factor Receptor c-met in {beta}-Cells Leads to Defective Insulin Secretion and GLUT-2 Downregulation Without Alteration of {beta}-Cell Mass Diabetes, July 1, 2005; 54(7): 2090 - 2102. [Abstract] [Full Text] [PDF]

				Y. Guo, Y. Lu, D. Houle, K. Robertson, Z. Tang, J. J. Kopchick, Y. L. Liu, and J.-L. Liu Pancreatic Islet-Specific Expression of an Insulin-Like Growth Factor-I Transgene Compensates Islet Cell Growth in Growth Hormone Receptor Gene-Deficient Mice Endocrinology, June 1, 2005; 146(6): 2602 - 2609. [Abstract] [Full Text] [PDF]

				Y. Lu, P. L. Herrera, Y. Guo, D. Sun, Z. Tang, D. LeRoith, and J.-L. Liu Pancreatic-Specific Inactivation of IGF-I Gene Causes Enlarged Pancreatic Islets and Significant Resistance to Diabetes Diabetes, December 1, 2004; 53(12): 3131 - 3141. [Abstract] [Full Text] [PDF]

				E. A. Joanette, B. Reusens, E. Arany, S. Thyssen, R. C. Remacle, and D. J. Hill Low-Protein Diet during Early Life Causes a Reduction in the Frequency of Cells Immunopositive for Nestin and CD34 in Both Pancreatic Ducts and Islets in the Rat Endocrinology, June 1, 2004; 145(6): 3004 - 3013. [Abstract] [Full Text] [PDF]

				R. Robitaille, J. Dusseault, N. Henley, L. Rosenberg, and J.-P. Halle Insulin-Like Growth Factor II Allows Prolonged Blood Glucose Normalization with a Reduced Islet Cell Mass Transplantation Endocrinology, July 1, 2003; 144(7): 3037 - 3045. [Abstract] [Full Text] [PDF]

				W. Liu, C. Chin-Chance, E.-J. Lee, and W. L. Lowe Jr. Activation of Phosphatidylinositol 3-Kinase Contributes to Insulin-Like Growth Factor I-Mediated Inhibition of Pancreatic {beta}-Cell Death Endocrinology, October 1, 2002; 143(10): 3802 - 3812. [Abstract] [Full Text] [PDF]

				A. Cebrian, A. Garcia-Ocana, K. K. Takane, D. Sipula, A. F. Stewart, and R. C. Vasavada Overexpression of Parathyroid Hormone-Related Protein Inhibits Pancreatic {beta}-Cell Death In Vivo and In Vitro Diabetes, October 1, 2002; 51(10): 3003 - 3013. [Abstract] [Full Text] [PDF]

				P. Serradas, L. Goya, M. Lacorne, M.-N. Gangnerau, S. Ramos, C. Alvarez, A.-M. Pascual-Leone, and B. Portha Fetal Insulin-Like Growth Factor-2 Production Is Impaired in the GK Rat Model of Type 2 Diabetes Diabetes, February 1, 2002; 51(2): 392 - 397. [Abstract] [Full Text] [PDF]

				J. Nakae, Y. Kido, and D. Accili Distinct and Overlapping Functions of Insulin and IGF-I Receptors Endocr. Rev., December 1, 2001; 22(6): 818 - 835. [Abstract] [Full Text] [PDF]

				A. L Fowden and D. J Hill Intra-uterine programming of the endocrine pancreas Br. Med. Bull., November 1, 2001; 60(1): 123 - 142. [Abstract] [Full Text] [PDF]

				L. Rachdi, L. El Ghazi, F. Bernex, J.-J. Panthier, P. Czernichow, and R. Scharfmann Expression of the Receptor Tyrosine Kinase KIT in Mature {beta}-Cells and in the Pancreas in Development Diabetes, September 1, 2001; 50(9): 2021 - 2028. [Abstract] [Full Text] [PDF]